139 related articles for article (PubMed ID: 9473129)
1. Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1997 Nov; 339(2-3):153-6. PubMed ID: 9473129
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of McN-A-343 on membrane current and contraction in guinea pig ventricular myocytes.
Shen JB; Jiang B; Pappano AJ
J Pharmacol Exp Ther; 1999 Aug; 290(2):641-8. PubMed ID: 10411573
[TBL] [Abstract][Full Text] [Related]
3. Distinct functional muscarinic receptors in guinea-pig gallbladder, ileum and atria.
Karaalp A; Akici A; Akbulut H; Ulusoy NB; Oktay S
Pharmacol Res; 1999 May; 39(5):389-95. PubMed ID: 10328997
[TBL] [Abstract][Full Text] [Related]
4. Receptor signaling mechanisms underlying muscarinic agonist-evoked contraction in guinea-pig ileal longitudinal smooth muscle.
Unno T; Kwon SC; Okamoto H; Irie Y; Kato Y; Matsuyama H; Komori S
Br J Pharmacol; 2003 May; 139(2):337-50. PubMed ID: 12770939
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification.
Eglen RM; Kenny BA; Michel AD; Whiting RL
Br J Pharmacol; 1987 Apr; 90(4):693-700. PubMed ID: 2437988
[TBL] [Abstract][Full Text] [Related]
6. The interaction of McN-A-343 with muscarine receptors in cardiac and smooth muscle.
Elnatan A; Mitchelson F
Biochem Pharmacol; 1993 Sep; 46(6):993-1003. PubMed ID: 7692853
[TBL] [Abstract][Full Text] [Related]
7. Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
Micheletti R; Schiavone A
J Pharmacol Exp Ther; 1990 Apr; 253(1):310-4. PubMed ID: 1691785
[TBL] [Abstract][Full Text] [Related]
8. The design and pharmacology of novel selective muscarinic agonists and antagonists.
Lambrecht G; Gross J; Hacksell U; Hermanni U; Hildebrandt C; Hou X; Moser U; Nilsson BM; Pfaff O; Waelbroeck M
Life Sci; 1995; 56(11-12):815-22. PubMed ID: 10188780
[TBL] [Abstract][Full Text] [Related]
9. Functional partial agonism at cloned human muscarinic acetylcholine receptors.
Bräuner-Osborne H; Ebert B; Brann MR; Falch E; Krogsgaard-Larsen P
Eur J Pharmacol; 1996 Oct; 313(1-2):145-50. PubMed ID: 8905341
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of carbachol, McN-A-343 and AHR-602 on Ca(2+)-mobilization and Ca(2+)-influx pathways in taenia caeci.
Hishinuma S; Hongo I; Matsumoto Y; Narita F; Kurokawa M
Br J Pharmacol; 1997 Nov; 122(6):985-92. PubMed ID: 9401759
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic M1 receptor activation reduces maximum upstroke velocity of action potential in mouse right atria.
Islam MA; Nojima H; Kimura I
Eur J Pharmacol; 1998 Apr; 346(2-3):227-36. PubMed ID: 9652364
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes.
Adachi S; Koike K; Takayanagi I
Pharmacology; 1996 Oct; 53(4):250-8. PubMed ID: 8958564
[TBL] [Abstract][Full Text] [Related]
13. Deoxamuscaroneoxime derivatives as useful muscarinic agonists to explore the muscarinic subsite: demox, a modulator of orthosteric and allosteric sites at cardiac muscarinic M2 receptors.
Angeli P; Marucci G; Buccioni M; Piergentili A; Giannella M; Quaglia W; Pigini M; Cantalamessa F; Nasuti C; Novi F; Maggio R; Qasem AR; Spampinato S
Life Sci; 2002 Feb; 70(12):1427-46. PubMed ID: 11883718
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the positive and negative inotropic effects of acetylcholine in the human myocardium.
Du XY; Schoemaker RG; Bos E; Saxena PR
Eur J Pharmacol; 1995 Sep; 284(1-2):119-27. PubMed ID: 8549614
[TBL] [Abstract][Full Text] [Related]
15. Carbachol activates a novel sodium current in isolated guinea pig ventricular myocytes via M2 muscarinic receptors.
Matsumoto K; Pappano AJ
Mol Pharmacol; 1991 Mar; 39(3):359-63. PubMed ID: 1706471
[TBL] [Abstract][Full Text] [Related]
16. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
Eltze M
Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317
[TBL] [Abstract][Full Text] [Related]
17. Differential Rho-kinase dependency of full and partial muscarinic receptor agonists in airway smooth muscle contraction.
Schaafsma D; Boterman M; de Jong AM; Hovens I; Penninks JM; Nelemans SA; Meurs H; Zaagsma J
Br J Pharmacol; 2006 Apr; 147(7):737-43. PubMed ID: 16432505
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
[TBL] [Abstract][Full Text] [Related]
19. The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart.
Birdsall NJ; Burgen AS; Hulme EC; Stockton JM; Zigmond MJ
Br J Pharmacol; 1983 Feb; 78(2):257-9. PubMed ID: 6187403
[TBL] [Abstract][Full Text] [Related]
20. [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]-trimethylammonium (McN-A-343)-related compounds. Effect of the butynyl chain inclusion into an aromatic unit on the potency for muscarinic receptors.
Tumiatti V; Angeli P; Andrisano V; Bolognesi ML; Cavalli A; Marucci G; Minarini A; Recanatini M; Rosini M; Melchiorre C
Bioorg Med Chem; 2000 Apr; 8(4):681-9. PubMed ID: 10819156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]